543
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of the skin sensitization potential of chemicals in THP-1/keratinocyte co-cultures

, , , , , , & show all
Pages 196-204 | Received 10 Apr 2011, Accepted 24 May 2011, Published online: 01 Jul 2011

References

  • Magnusson, B., Kligman, A.M. The identification of contact allergens by animal assay. The guinea pig maximization test. J Invest Dermatol 1969, 52, 268–276.
  • Basketter, D., Cockshott, A., Corsini, E., Gerberick, G.F., Idehara, K., Kimber, I., Van Loveren, H., Matheson, J., Mehling, A., Omori, T., Rovida, C., Sozu, T., Takeyoshi, M., Casati, S. An evaluation of performance standards and non-radioactive endpoints for the local lymph node assay. The report and recommendations of ECVAM Workshop 65. Altern Lab Anim 2008, 36, 243–257.
  • Basketter, D.A., Dearman, R.J., Kimber, I., Gerberick, G.F., Ryan, C.A. The impact of LLNA group size on the identification and potency classification of skin sensitizers: a review of published data. Cutan Ocul Toxicol 2009, 28, 19–22.
  • Ryan, C.A., Hulette, B.C., Gerberick, G.F. Approaches for the development of cell-based in vitro methods for contact sensitization. Toxicol In Vitro 2001, 15, 43–55.
  • Basketter, D., Maxwell, G. In vitro approaches to the identification and characterization of skin sensitizers. Cutan Ocul Toxicol 2007, 26, 359–373.
  • Grindon, C., Combes, R., Cronin, M.T., Roberts, D.W., Garrod, J.F. An integrated decision-tree testing strategy for skin sensitisation with respect to the requirements of the EU REACH legislation. Altern Lab Anim 2007, 35, 683–697.
  • Moulon, C., Péguet-Navarro, J., Courtellemont, P., Redziniak, G., Schmitt, D. Human in vitro T cell sensitization using hapten-modified epidermal Langerhans cells. Adv Exp Med Biol 1993, 329, 209–212.
  • Moulon, C., Péguet-Navarro, J., Courtellemont, P., Redziniak, G., Schmitt, D. In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans’ cells. Immunology 1993, 80, 373–379.
  • Krasteva, M., Peguet-Navarro, J., Moulon, C., Courtellemont, P., Redziniak, G., Schmitt, D. In vitro primary sensitization of hapten-specific T cells by cultured human epidermal Langerhans cells–a screening predictive assay for contact sensitizers. Clin Exp Allergy 1996, 26, 563–570.
  • Coutant, K.D., de Fraissinette, A.B., Cordier, A., Ulrich, P. Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen. Toxicol Sci 1999, 52, 189–198.
  • Guironnet, G., Dalbiez-Gauthier, C., Rousset, F., Schmitt, D., Péguet-Navarro, J. In vitro human T cell sensitization to haptens by monocyte-derived dendritic cells. Toxicol In Vitro 2000, 14, 517–522.
  • Tuschl, H., Kovac, R., Weber, E. The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals. Toxicol In Vitro 2000, 14, 541–549.
  • Pichowski, J.S., Cumberbatch, M., Dearman, Basketter, D.A., Kimber, I. Investigation of induced changes in interleukin 1beta mRNA expression by cultured human dendritic cells as an in vitro approach to skin sensitization testing. Toxicol In Vitro 2000, 14, 351–360.
  • Aiba, S., Manome, H., Nakagawa, S., Mollah, Z.U., Mizuashi, M., Ohtani, T., Yoshino, Y., Tagami, H. p38 Mitogen-activated protein kinase and extracellular signal-regulated kinases play distinct roles in the activation of dendritic cells by two representative haptens, NiCl2 and 2,4-dinitrochlorobenzene. J Invest Dermatol 2003, 120, 390–399.
  • Arrighi, J.F., Zubler, R., Hauser, C., Irion, O., Brouwers, N., Chapuis, B., Kindler, V. CD34(+) cord blood cells expressing cutaneous lymphocyte-associated antigen are enriched in granulocyte-macrophage progenitors and support extensive amplification of dendritic cell progenitors. Exp Hematol 2001, 29, 1029–1037.
  • Boislève, F., Kerdine-Römer, S., Pallardy, M. Implication of the MAPK pathways in the maturation of human dendritic cells induced by nickel and TNF-alpha. Toxicology 2005, 206, 233–244.
  • Boislève, F., Kerdine-Römer, S., Rougier-Larzat, N., Pallardy, M. Nickel and DNCB induce CCR7 expression on human dendritic cells through different signalling pathways: role of TNF-alpha and MAPK. J Invest Dermatol 2004, 123, 494–502.
  • Ashikaga, T., Hoya, M., Itagaki, H., Katsumura, Y., Aiba, S. Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers. Toxicol In Vitro 2002, 16, 711–716.
  • Yoshida, Y., Sakaguchi, H., Ito, Y., Okuda, M., Suzuki, H. Evaluation of the skin sensitization potential of chemicals using expression of co-stimulatory molecules, CD54 and CD86, on the naive THP-1 cell line. Toxicol In Vitro 2003, 17, 221–228.
  • Python, F., Goebel, C., Aeby, P. Assessment of the U937 cell line for the detection of contact allergens. Toxicol Appl Pharmacol 2007, 220, 113–124.
  • Hulette, B.A., Ryan, C.A., Gerberick, G.F. Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment. Toxicol Appl Pharmacol 2002, 182, 226–233.
  • Azam, P., Peiffer, J.L., Chamousset, D., Tissier, M.H., Bonnet, P.A., Vian, L., Fabre, I., Ourlin, J.C. The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers. Toxicol Appl Pharmacol 2006, 212, 14–23.
  • Casati, S., Aeby, P., Basketter, D.A., Cavani, A., Gennari, A., Gerberick, G.F., Griem, P., Hartung, T., Kimber, I., Lepoittevin, J.P., Meade, B.J., Pallardy, M., Rougier, N., Rousset, F., Rubinstenn, G., Sallusto, F., Verheyen, G.R., Zuang, V.; Report and Recommendations of ECVAM Workshop 51. Dendritic cells as a tool for the predictive identification of skin sensitisation hazard. Altern Lab Anim 2005, 33, 47–62.
  • Caux, C., Vanbervliet, B., Massacrier, C., Durand, I., Banchereau, J. Interleukin-3 cooperates with tumor necrosis factor alpha for the development of human dendritic/Langerhans cells from cord blood CD34+ hematopoietic progenitor cells. Blood 1996, 87, 2376–2385.
  • Aiba, S., Terunuma, A., Manome, H., Tagami, H. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur J Immunol 1997, 27, 3031–3038.
  • Pichowski, J.S., Cumberbatch, M., Dearman, R.J., Basketter, D.A., Kimber, I. Allergen-induced changes in interleukin 1 beta (IL-1 beta) mRNA expression by human blood-derived dendritic cells: inter-individual differences and relevance for sensitization testing. J Appl Toxicol 2001, 21, 115–121.
  • Ashikaga, T., Yoshida, Y., Hirota, M., Yoneyama, K., Itagaki, H., Sakaguchi, H., Miyazawa, M., Ito, Y., Suzuki, H., Toyoda, H. Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. Toxicol In Vitro 2006, 20, 767–773.
  • Sakaguchi H, Ryan C, Ovigne JM, Schroeder KR, Ashikaga T. Predicting skin sensitization potential and inter-laboratory reproducibility of a human Cell Line Activation Test (h-CLAT) in the European Cosmetics Association (COLIPA) ring trials. Toxicol In Vitro 2010.
  • Sakaguchi, H., Miyazawa, M., Yoshida, Y., Ito, Y., Suzuki, H. Prediction of preservative sensitization potential using surface marker CD86 and/or CD54 expression on human cell line, THP-1. Arch Dermatol Res 2007, 298, 427–437.
  • Sakaguchi, H., Ashikaga, T., Miyazawa, M., Yoshida, Y., Ito, Y., Yoneyama, K., Hirota, M., Itagaki, H., Toyoda, H., Suzuki, H. Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. Toxicol In Vitro 2006, 20, 774–784.
  • Sakaguchi, H., Ashikaga, T., Miyazawa, M., Kosaka, N., Ito, Y., Yoneyama, K., Sono, S., Itagaki, H., Toyoda, H., Suzuki, H. The relationship between CD86/CD54 expression and THP-1 cell viability in an in vitro skin sensitization test–human cell line activation test (h-CLAT). Cell Biol Toxicol 2009, 25, 109–126.
  • Vandebriel, R.J., Pennings, J.L., Baken, K.A., Pronk, T.E., Boorsma, A., Gottschalk, R., Van Loveren, H. Keratinocyte gene expression profiles discriminate sensitizing and irritating compounds. Toxicol Sci 2010, 117, 81–89.
  • Vandebriel, R.J., van Loveren, H. Non-animal sensitization testing: state-of-the-art. Crit Rev Toxicol 2010, 40, 389–404.
  • Vandebriel, R.J., Van Och, F.M., van Loveren, H. In vitro assessment of sensitizing activity of low molecular weight compounds. Toxicol Appl Pharmacol 2005, 207, 142–148.
  • Cumberbatch, M., Dearman, R.J., Groves, R.W., Antonopoulos, C., Kimber, I. Differential regulation of epidermal langerhans cell migration by interleukins (IL)-1alpha and IL-1beta during irritant- and allergen-induced cutaneous immune responses. Toxicol Appl Pharmacol 2002, 182, 126–135.
  • Natsch, A., Emter, R. Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals. Toxicol Sci 2008, 102, 110–119.
  • Natsch, A., Emter, R., Ellis, G. Filling the concept with data: integrating data from different in vitro and in silico assays on skin sensitizers to explore the battery approach for animal-free skin sensitization testing. Toxicol Sci 2009, 107, 106–121.
  • Emter, R., Ellis, G., Natsch, A. Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro. Toxicol Appl Pharmacol 2010, 245, 281–290.
  • Corsini, E., Mitjans, M., Galbiati, V., Lucchi, L., Galli, C.L., Marinovich, M. Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens. Toxicol In Vitro 2009, 23, 789–796.
  • Schreiner, M., Peiser, M., Briechle, D., Stahlmann, R., Zuberbier, T., Wanner, R. A loose-fit coculture of activated keratinocytes and dendritic cell-related cells for prediction of sensitizing potential. Allergy 2007, 62, 1419–1428.
  • Wanner, R., Sonnenburg, A., Quatchadze, M., Schreiner, M., Peiser, M., Zuberbier, T., Stahlmann, R. Classification of sensitizing and irritative potential in a combined in-vitro assay. Toxicol Appl Pharmacol 2010, 245, 211–218.
  • Gerlier, D., Thomasset, N. Use of MTT colorimetric assay to measure cell activation. J Immunol Methods 1986, 94, 57–63.
  • Miyazawa, M., Ito, Y., Yoshida, Y., Sakaguchi, H., Suzuki, H. Phenotypic alterations and cytokine production in THP-1 cells in response to allergens. Toxicol In Vitro 2007, 21, 428–437.
  • Bergström, M.A., Ott, H., Carlsson, A., Neis, M., Zwadlo-Klarwasser, G., Jonsson, C.A., Merk, H.F., Karlberg, A.T., Baron, J.M. A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. J Invest Dermatol 2007, 127, 1145–1153.
  • Cumberbatch, M., Dearman, R.J., Griffiths, C.E., Kimber, I. Epidermal Langerhans cell migration and sensitisation to chemical allergens. APMIS 2003, 111, 797–804.
  • Van Och, F.M., Van Loveren, H., Van Wolfswinkel, J.C., Machielsen, A.J., Vandebriel, R.J. Assessment of potency of allergenic activity of low molecular weight compounds based on IL-1alpha and IL-18 production by a murine and human keratinocyte cell line. Toxicology 2005, 210, 95–109.
  • Barratt, M.D., Basketter, D.A. Possible origin of the skin sensitization potential of isoeugenol and related compounds. (I). Preliminary studies of potential reaction mechanisms. Contact Derm 1992, 27, 98–104.
  • White, I.R., Johansen, J.D., Arnau, E.G., Lepoittevin, J.P., Rastogi, S., Bruze, M., Andersen, K.E., Frosch, P.J., Goossens, A., Menné, T. Isoeugenol is an important contact allergen: can it be safely replaced with isoeugenyl acetate? Contact Derm 1999, 41, 272–275.
  • AI Masaoudi T, Sieben S, Callahan CP, Merk HF, Blömeke B. Eugenol but Not Isoeugenol Induces CYPIA1 mRNA in Human Keratinocytes. Int Arch Allergy Immunol 2001, 124, 309–311.
  • Sieben, S., Hertl, M., Al Masaoudi, T., Merk, H.F., Blömeke, B. Characterization of T cell responses to fragrances. Toxicol Appl Pharmacol 2001, 172, 172–178.
  • Baron, J.M., Zwadlo-Klarwasser, G., Jugert, F., Hamann, W., Rübben, A., Mukhtar, H., Merk, H.F. Cytochrome P450 1B1: a major P450 isoenzyme in human blood monocytes and macrophage subsets. Biochem Pharmacol 1998, 56, 1105–1110.
  • Sieben, S., Baron, J.M., Blömeke, B., Merk, H.F. Multiple cytochrome P450-isoenzymes mRNA are expressed in dendritic cells. Int Arch Allergy Immunol 1999, 118, 358–361.
  • Tietze, C., Blomeke, B. Sensitization assays: monocyte-derived dendritic cells versus a monocytic cell line (THP-1). J Toxicol Environ Health Part A 2008, 71, 965–968.
  • Ade, N., Leon, F., Pallardy, M., Peiffer, J.L., Kerdine-Romer, S., Tissier, M.H., Bonnet, P.A., Fabre, I., Ourlin, J.C. HMOX1 and NQO1 genes are upregulated in response to contact sensitizers in dendritic cells and THP-1 cell line: role of the Keap1/Nrf2 pathway. Toxicol Sci 2009, 107, 451–460.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.